STRATA Skin Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Rhea-AI Summary

STRATA Skin Sciences (NASDAQ: SSKN), a medical technology company focused on dermatologic treatments, announces its participation in the 2024 Maxim Healthcare Virtual Summit. President and CEO Dr. Dolev Rafaeli will engage in a fireside chat with Maxim's Director of Research and Senior Healthcare Analyst Anthony Vendetti on Wednesday, October 16, 2024, at 11:30am ET.

The virtual conference runs from October 15 to 17, 2024. Investors can access the fireside chat via webcast at https://m-vest.com/events/healthcare-10152024. Additionally, Dr. Rafaeli and STRATA V.P. Finance John Gillings will be available for one-on-one meetings with registered conference investors.

HORSHAM, Pa., Oct. 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and CEO Dr. Dolev Rafaeli will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit with Maxim Director of Research and Senior Healthcare Analyst Anthony Vendetti. The conference is being held virtually on October 15 – 17, 2024.

Event:	Fireside Chat at 2024 Maxim Healthcare Virtual Summit
Date:	Wednesday, October 16, 2024
Time:	11:30am ET
Webcast:	https://m-vest.com/events/healthcare-10152024

Dr. Rafaeli and STRATA V.P. Finance John Gillings will be available for one-on-one meetings with registered investors of the conference.

About STRATA Skin Sciences
STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing, and marketing innovative products for the in-office treatment of various dermatologic conditions, such as psoriasis, vitiligo, and acne. Its products include the XTRAC^® excimer laser, VTRAC^® lamp systems, and the TheraClear^®X Acne Therapy System.

STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA’s popular partnership approach includes a fee per treatment cost structure (versus an equipment purchase), installation and use of the device, on-site training for practice personnel, service and maintenance of the equipment, dedicated account and customer service associates, and co-op advertising support to help raise awareness and promote the program within the practice.

Safe Harbor
This press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to the Company’s plans, objectives, expectations and intentions and may contain words such as “will,” “may,” “seeks,” and “expects,” that suggest future events or trends. These statements, the Company’s ability to launch and sell products recently acquired or to be developed in the future, the Company’s ability to develop social media marketing campaigns, direct to consumer marketing campaigns, and the Company’s ability to build a leading franchise in dermatology and aesthetics, are based on the Company’s current expectations and are inherently subject to significant uncertainties and changes in circumstances. Actual results may differ materially from the Company’s expectations due to financial, economic, business, competitive, market, regulatory, adverse market conditions labor supply shortages, or supply chain interruptions resulting from fiscal, political factors, international conflicts, responses, or conditions affecting the Company, the medical device industry and our customers and patients in general, as well as more specific risks and uncertainties set forth in the Company’s SEC reports on Forms 10-Q and 10-K. Given such uncertainties, any or all these forward-looking statements may prove to be incorrect or unreliable. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not undertake any obligation to update or revise these statements to reflect events or circumstances occurring after the date of this press release. The Company urges investors to carefully review its SEC disclosures available at www.sec.gov and www.strataskinsciences.com.

Investor Contact:
CORE IR
516-222-2560
IR@strataskin.com

FAQ

When is STRATA Skin Sciences (SSKN) participating in the 2024 Maxim Healthcare Virtual Summit?

STRATA Skin Sciences (SSKN) is participating in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16, 2024, at 11:30am ET.

Who will represent STRATA Skin Sciences (SSKN) at the 2024 Maxim Healthcare Virtual Summit?

Dr. Dolev Rafaeli, President and CEO of STRATA Skin Sciences, will represent the company in a fireside chat at the 2024 Maxim Healthcare Virtual Summit.

How can investors access STRATA Skin Sciences' (SSKN) fireside chat at the Maxim Healthcare Virtual Summit?

Investors can access STRATA Skin Sciences' (SSKN) fireside chat via webcast at https://m-vest.com/events/healthcare-10152024.

Will STRATA Skin Sciences (SSKN) offer one-on-one meetings with investors at the 2024 Maxim Healthcare Virtual Summit?

Yes, Dr. Dolev Rafaeli and STRATA V.P. Finance John Gillings will be available for one-on-one meetings with registered investors of the conference.